Results 191 to 200 of about 23,184,450 (240)
Some of the next articles are maybe not open access.
Quantitative Structure–Activity Relationships of Antimicrobial Compounds
2012A thorough antimicrobial reviewof an increasing number of reports reveals a broad spectrum of research activity in the development practices that are used to treat a variety of diseases. The quantitative relationship between chemical structure and biological activity has received considerable attention in recent years because it allows one to predict ...
Maguna, Fabiana Paola +2 more
openaire +2 more sources
Quantitative Structure-Activity Relationships of Renin Inhibitors
Mini-Reviews in Medicinal Chemistry, 2003A review is presented on quantitative structure-activity relationships (QSARs) of renin inhibitors which have potential as antihypertensive and cardiovascular agents. They inhibit the renin, an enzyme that is involved in the rate-limiting first step of the renin angiotensin system (RAS).
openaire +2 more sources
STERIC EFFECTS IN QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS
Pure and Applied Chemistry, 1978Abstract
openaire +1 more source
Sorption and Quantitative Structure-Activity Relationship (QSAR)
2014The sorption of pesticides to soils or sediments is the major factor determining their mobility, transport and bioavailability in terrestrial and aquatic environments. The organic matter is the primary sorption domain in soils or sediments and sorption is considered to be primarily a partitioning process between soil organic matter and the surrounding ...
Aleksandar Sabljic, Yoshiaki Nakagawa
openaire +1 more source
Quantitative Structure-Activity Relationships of Antiarrhythmic Drugs
Current Pharmaceutical Design, 1998Abstract: A Comprehensive review of quantitative structure-activity relationship (QSAR) studies on antiarrhythmic agents is presented. From the discussion point of view, the antiarrhythmic agents have been put into two broad classes: specific and nonspecific.
openaire +2 more sources
Quantitative structure-activity relationships of antianginal drugs
2001Quantitative structure-activity relationships (QSARs) of various classes of antianginal drugs, e.g. nitrates, beta-adrenergic blocking agents (beta-blockers), and calcium channel blockers (calcium antagonists), have been reviewed. This review gives an overall picture of the mode of action of each class of drugs and points out the specific ...
openaire +2 more sources
Quantitative structure - activity relationships of cardiotonic agents
2000Quantitative structure-activity relationships (QSARs) of different cardiotonic agents are presented. A critical analysis of all QSARs provides a very vivid picture of the mechanisms of varying cardiotonic agents. The cardiotonics can be broadly put into 2 categories: cardiac glycosides and nonglycoside cardiotonics, which include phosphodiesterase of ...
openaire +2 more sources
Quantitative structure-activity relationships for skin permeability
Toxicology in Vitro, 1995In vitro human skin permeability coefficient data collected by Flynn (1990) have been analysed using multiple regression analysis. An improved model for the prediction of permeability coefficients has been derived by the inclusion of the melting point as an independent variable in addition to the octanol-water partition coefficient (as logP) and ...
openaire +2 more sources
Chromatography in studies of quantitative structure-activity relationships
Journal of Chromatography A, 1981The rational bases, experimental techniques and conditions required for the chromatographic determination of the structural data of importance for studies on quantitative relationships between chemical structure and biological activity of drugs (QSAR) are reviewed. Practical applications of the information gathered from various chromatographic modes in
openaire +2 more sources
Quantitative structure-activity relationships of antihypertensive agents
1999Quantitative structure-activity relationships of various classes of antihypertensive agents, e.g., sympatholytic agents, diuretics, direct or peripheral vasodilators, potassium channel activators, angiotensin-converting enzyme inhibitors, renin inhibitors and miscellaneous agents (platelet aggregation inhibitors) are reviewed.
openaire +2 more sources

